GeneDx Holdings Corp. (WGS)

Last Closing Price: 69.98 (2025-05-29)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

GeneDx Holdings Corp. (WGS) had Net Income of $-6.53M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$87.11M
Net Income
$-6.53M
$28.64M
$58.48M
$91.67M
$-4.55M
$-1.53M
$-6.08M
$-6.08M
$-6.53M
$-6.53M
$-6.53M
$-6.53M
$-4.55M
$1.13M
28.15M
28.15M
$-0.23
$-0.23
Balance Sheet Financials
$225.82M
$36.38M
$220.61M
$446.43M
$69.54M
$51.79M
$119.48M
$189.03M
$257.40M
$102.31M
$257.40M
28.53M
Cash Flow Statement Financials
$10.18M
$-9.41M
$13.72M
$86.20M
$100.69M
$14.49M
$3.98M
--
--
Fundamental Metrics & Ratios
3.25
--
--
0.17
0.20
67.13%
-5.22%
-5.22%
--
-6.98%
-7.49%
$4.05M
--
--
--
0.20
2.26
1.89
47.51
-2.54%
-6.38%
-1.46%
-2.11%
$9.02
$0.14
$0.36